{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:04:45Z","timestamp":1779955485079,"version":"3.53.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1102494"],"award-info":[{"award-number":["1102494"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BELL190A"],"award-info":[{"award-number":["BELL190A"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jcf.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T11:16:04Z","timestamp":1752750964000},"page":"903-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-0805","authenticated-orcid":false,"given":"Ieuan ES","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-3055","authenticated-orcid":false,"given":"Christine M","family":"Duplancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8389-3809","authenticated-orcid":false,"given":"Claire E","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-7139","authenticated-orcid":false,"given":"Scott C","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jcf.2025.07.002_bib0001","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/cid\/ciy215","article-title":"Changing rates of chronic Pseudomonas aeruginosa infections in Cystic fibrosis: a population-based cohort study","volume":"67","author":"Crull","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0002","doi-asserted-by":"crossref","first-page":"00336","DOI":"10.1183\/23120541.00336-2022","article-title":"Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis","volume":"9","author":"Prieto","year":"2023","journal-title":"ERJ Open Res"},{"issue":"9","key":"10.1016\/j.jcf.2025.07.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00193-18","article-title":"Pathogen eradication\u201d and \u201cemerging pathogens\u201d: difficult definitions in Cystic fibrosis","volume":"56","author":"Gilligan","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0004","doi-asserted-by":"crossref","first-page":"e01217","DOI":"10.1128\/mBio.01217-20","article-title":"Same game, different players: emerging pathogens of the CF lung","volume":"12","author":"Gannon","year":"2021","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.002_bib0005","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2019.08.006","article-title":"Changing epidemiology of the respiratory bacteriology of patient with cystic fibrosis \u2013 data from the European cystic fibrosis society patient registry","volume":"19","author":"Hatziagorou","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2025.07.002_bib0006","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ppul.23185","article-title":"Geographic variations in cystic fibrosis: an analysis of the U.S. CF Foundation Registry","volume":"50","author":"Kopp","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcf.2016.07.010","article-title":"The changing prevalence of pulmonary infection in adults with cystic fibrosis: a longitudinal analysis","volume":"16","author":"Ramsay","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2025.07.002_bib0008","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.00060512","article-title":"Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres","volume":"41","author":"Kidd","year":"2013","journal-title":"ERJ"},{"issue":"7","key":"10.1016\/j.jcf.2025.07.002_bib0009","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1440-1843.2009.01595.x","article-title":"Multi-centre research in Australia: analysis of a recent National Health and Medical Research Council-funded project","volume":"14","author":"Kidd","year":"2009","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.jcf.2025.07.002_bib0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/imj.14158","article-title":"Multi-centre ethics and research governance review can impede non-interventional clinical research","volume":"49","author":"Duplancic","year":"2019","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0011","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jpc.15747","article-title":"Ethics and governance for a multi-site study in Australia: navigating the snakes and ladders","volume":"58","author":"Samir","year":"2022","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.jcf.2025.07.002_bib0012","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1071\/AH20022","article-title":"Challenges in obtaining research ethics and governance approvals for an Australian national intersector, multisite audit study","volume":"44","author":"Buck","year":"2020","journal-title":"Aust Health Rev"},{"key":"10.1016\/j.jcf.2025.07.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077132","article-title":"Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions","volume":"14","author":"Gumber","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcf.2025.07.002_bib0014","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/S1569-1993(24)00394-1","article-title":"P090 Mission (almost) impossible: setting up a complex investigator led international adaptive platform trial - finding the optimal regimen for mycobacterium abscessus treatment (FORMaT)","volume":"23","author":"Jong","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2025.07.002_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","article-title":"PROMISE: working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy","volume":"20","author":"Nichols","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.07.002_bib0016","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2023.11.013","article-title":"Use of elexacaftor\/tezacaftor\/ivacaftor leads to changes in detection frequency of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis","volume":"139","author":"Dittrich","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jcf.2025.07.002_bib0017","unstructured":"Ahern S, Pourghaderi AR, Ruseckaite R, Caruso M, Liman J, Wark P, Schultz A, Armstrong J, on behalf of the ACFDR. The ACFDR Registry Annual Report, 2023. School of Public Health and Preventive Medicine, Monash University, July 2024, Report No 25. (accessed \u2013 18\/03\/2025). https:\/\/www.cysticfibrosis.org.au\/wp-content\/uploads\/2024\/07\/ACFDR_2023_Annual-Report.pdf."},{"key":"10.1016\/j.jcf.2025.07.002_bib0018","first-page":"00111","article-title":"Exploring reduced pulmonary exacerbation rates in cystic fibrosis: a pandemic or modulator effect?","author":"Stephenson","year":"2025","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.jcf.2025.07.002_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/picr.PICR_198_18","article-title":"Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral centre: a five-year audit","volume":"11","author":"Bose","year":"2020","journal-title":"Perspect Clin Res"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/picr.picr_161_21","article-title":"Strategies for participant retention in long term clinical trials: a participant-centric approach","volume":"14","author":"Poongothai","year":"2022","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.jcf.2025.07.002_bib0021","first-page":"7","article-title":"Loss to follow-up","volume":"2","author":"Dettori","year":"2011","journal-title":"Evid Base Spine Care J"},{"key":"10.1016\/j.jcf.2025.07.002_bib0022","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41581-020-00336-9","article-title":"Impact of the COVID-19 pandemic on clinical research","volume":"16","author":"Tuttle","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.002_bib0023","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3126\/nje.v10i3.31622","article-title":"Impact of COVID-19 on clinical trials and clinical research: a systematic review","volume":"10","author":"Sathian","year":"2020","journal-title":"Nepal J Epidemiol"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.002_bib0024","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jacc.2020.05.041","article-title":"The consequences of the COVID-19 pandemic on Non-COVID-19 clinical trials","volume":"76","author":"Bagiella","year":"2020","journal-title":"JACC"},{"key":"10.1016\/j.jcf.2025.07.002_bib0026","unstructured":"Cystic Fibrosis Foundation Patient Registry, 2023 Annual Data Report, Bethesda, Maryland \u00a92024 Cystic Fibrosis Foundation. https:\/\/www.cff.org\/sites\/default\/files\/2024-09\/2023-Patient-Registry-Annual-Data-Report.pdf. (accessed 18\/03\/2025)."},{"issue":"9","key":"10.1016\/j.jcf.2025.07.002_bib0027","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/ppul.25560","article-title":"Change in CF care during COVID-19 pandemic: single-center experience in a middle-income setting","volume":"56","author":"Hatziagorou","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0028","doi-asserted-by":"crossref","first-page":"00588","DOI":"10.1183\/23120541.00588-2021","article-title":"Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study","volume":"8","author":"Thee","year":"2022","journal-title":"ERJ Open Res"},{"issue":"10","key":"10.1016\/j.jcf.2025.07.002_bib0029","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1513\/AnnalsATS.202105-532OC","article-title":"Changes in care during the COVID-19 pandemic for people with Cystic Fibrosis","volume":"19","author":"Sanders","year":"2022","journal-title":"Ann Am Thor Soc"},{"key":"10.1016\/j.jcf.2025.07.002_bib0030","unstructured":"Australian Teletrials Program, The Australian Teletrial Program (accessed 18\/02\/2025). https:\/\/australianteletrialprogram.gov.au\/."},{"issue":"7","key":"10.1016\/j.jcf.2025.07.002_bib0031","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/JCM.00471-16","article-title":"Evaluation of various culture Media for detection of rapidly growing mycobacteria from patients with cystic fibrosis","volume":"54","author":"Preece","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.002_bib0032","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12890-019-0781-2","article-title":"An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation","volume":"19","author":"Stephenson","year":"2019","journal-title":"BMC Pulm Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325015255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325015255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:36:09Z","timestamp":1779953769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325015255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1569199325015255"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.07.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}